Dell Technologies (NYSE: DELL) reports its quarterly earnings after the market closes today, May 29, 2025. Based on options pricing, traders are anticipating a move of approximately 9% in either direction. The stock has climbed more than 21% over the past month. As of the market open, Dell was trading at $114.30, up 0.47% from the previous close.Looking back at Dell’s post-earnings reactionsAnalysts anticipate the company will post revenue of $23.1 billion and adjusted earnings of $1.70 per share for the qu ...

以下文章来源于i黑马 ，作者i黑马 i黑马 . 让创业者不再孤独@i黑马 牛文文 创业黑马集团董事长&创始人 风口，无疑已经来了。 国运，无疑已经来了。 2025，中国中小企业的发展拐点，已然到来。 DeepSeek 带来 两个国运级的大机会： 第二， 中国产业智能化。 这两个国运级的大机会，马上就会普惠到全中国的产业和企业。 第一， 中国资产重估。 外行看热闹，内行看门道。 普通人跟 DeepSeek 玩一下就叫接入了。 但是如果你做企业级 的接入和应用，你必须是 核心产品、核心服务流程都 "DeepSeek化"了， 还要做到商业化提效。 现在是赢者通吃的一个时代，只有先行者，才能真正抓住这一轮大机会。 在这个情况下，创业黑马正式推出 中小企业级的 AI 实战营。 我们不但能给大家提供企业级的认知、方法论、资源 ，还会提供做企业级开发的供应商、人才 资源和投资资源。 3天2夜，带你用AI突破企业增长困局， 聚焦企业AI应用落地困惑， 运用"黑马AI增长画布， 助力企业用AI破局增长。 第一，在过去两年时间，我们黑马自己做了"天启政策大模型"。 目前， "天启政策大模型" 已成为工信部全国一张网七大板块中，找 ...

截至2025年5月29日 09点30分，中证大数据产业指数上涨0.06%，成分股千方科技上涨1.74%，新点软件上涨0.76%，紫光股份上涨0.55%，拓维信息上涨 0.51%，中国软件上涨0.45%。数据ETF（516000）上涨0.34%，最新价报0.88元。拉长时间看，截至2025年5月28日，数据ETF近1年累计上涨31.98%，领 涨同类。 数据ETF（516000）及其联接基金（A类：020335；C类：020336；D类：023779）紧密跟踪中证大数据产业指数，成分股主要聚焦DeepSeek、AI算力、 鸿蒙产业链等热门概念板块，覆盖科大讯飞、中科曙光、浪潮信息、恒生电子等热门个股，为投资者把握算力领域投资机会。 流动性方面，数据ETF盘中换手3.04%，成交1264.11万元。拉长时间看，截至5月28日，数据ETF近1年日均成交1707.12万元。 份额方面，数据ETF最新份额达4.72亿份，创近1月新高。 资金流入方面，数据ETF最新资金净流入352.48万元。拉长时间看，近10个交易日内有6日资金净流入，合计"吸金"1986.37万元，日均净流入达198.64万 元。 消息面上，工信部、 ...

Core Insights - Nutanix reported revenue of $638.98 million for the quarter ended April 2025, marking a year-over-year increase of 21.8% and an EPS of $0.42 compared to $0.28 a year ago, exceeding the Zacks Consensus Estimate of $626.12 million by 2.06% [1] Financial Performance - Total Billings reached $647.05 million, below the average estimate of $676.02 million from four analysts [4] - Annual Recurring Revenue (ARR) was reported at $2.14 billion, slightly below the average estimate of $2.17 billion from four analysts [4] - Professional services billings were $18.48 million, significantly lower than the average estimate of $32.78 million from three analysts [4] - Subscription billings amounted to $627.25 million, surpassing the average estimate of $616.58 million from two analysts [4] - Other non-subscription product billings were $1.32 million, below the average estimate of $1.68 million from two analysts [4] Revenue Breakdown - Revenue from support, entitlements, and other services was $293.50 million, below the average estimate of $312.03 million from eight analysts, reflecting a year-over-year change of +9.1% [4] - Product revenue was $345.48 million, exceeding the average estimate of $310.26 million from eight analysts, representing a year-over-year increase of +35.2% [4] - Professional services revenue was $28 million, slightly below the average estimate of $28.12 million from seven analysts, with a year-over-year change of +6.7% [4] - Subscription revenue reached $609.66 million, above the average estimate of $594.37 million from seven analysts, indicating a year-over-year increase of +25.3% [4] - Non-portable software revenue was $0.50 million, significantly below the average estimate of $2.59 million from seven analysts, showing a drastic year-over-year decline of -95.5% [4] Stock Performance - Nutanix shares have returned +15.3% over the past month, outperforming the Zacks S&P 500 composite's +7.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Group 1 - A-shares showed mixed performance with major indices declining, while sectors like gold jewelry, dairy, nuclear power, and optical communication were active [1] - The AI application sector is still in its early stages, with potential for growth driven by increasing application scenarios and token consumption, supported by advancements in domestic AI chip capabilities [1] - The domestic CPU market is expected to see new growth opportunities due to the implementation of domestic innovation policies in government and industry sectors [1] Group 2 - The cloud computing 50 ETF has a high AI computing content, covering sectors such as optical modules, data storage, and liquid cooling, with a significant portion of DeepSeek concept stocks [2] - The management and custody fees for the cloud computing 50 ETF are among the lowest in the market at a combined rate of 0.2% [2]

Core Insights - Carvana (CVNA) stock has reached a 52-week high of $312, gaining over 50% in 2025 and more than 800% over the last three years, outperforming peers like Amazon and MercadoLibre [1][2] - The company's end-to-end online business model covers all aspects of used-car retailing, and it is only 15% away from its all-time high of $370 reached in August 2021 [2] Financial Performance - Carvana's strong financial results are attributed to cost-cutting initiatives and debt restructuring, with total liabilities at $7.1 billion, below total assets of $8.87 billion [5] - In Q1, Carvana reported an EPS of $1.51, a significant improvement from an adjusted loss of $0.41 in the previous period, exceeding expectations of $0.75 by 101%. Q1 sales increased by 38% year-over-year to $4.23 billion, surpassing estimates of $4.04 billion [6] Growth Projections - Carvana is expected to increase total sales by 31% in fiscal 2025 and by another 25% in FY26, reaching $22.55 billion [7] - Annual earnings are projected to soar by 192% this year to $4.64 per share, compared to EPS of $1.59 in 2024, with FY26 EPS expected to rise another 33% to $6.16 [7] EPS Revisions - FY25 and FY26 EPS estimates have increased by 35% and 23% over the last 90 days, respectively, indicating a positive growth trajectory [10] - Current EPS estimates for FY25 and FY26 are $4.64 and $6.16, respectively, showing a consistent upward trend in earnings expectations [11] Valuation Insights - Carvana stock is trading at a premium with a forward P/E ratio of 65.5X, but positive EPS revisions are helping to balance the valuation [12] - The stock holds a Zacks Rank 1 (Strong Buy), suggesting potential for further upside [12]

NeuroPace (NPCE) Update Summary Company Overview - **Company**: NeuroPace (NPCE) - **Industry**: Medical Devices, specifically focused on epilepsy treatment Key Points and Arguments 1. **NAUGHTLIST Study Results**: Preliminary one-year results from the NAUGHTLIST study were released, supporting an expanded clinical indication for idiopathic generalized epilepsy (IGE) [2][5] 2. **Safety and Effectiveness**: The trial met its primary safety endpoint but did not reach statistical significance for its primary effectiveness endpoint. However, there was observed efficacy in a clinically meaningful subgroup of patients [5][11] 3. **Patient Improvement**: Patients experienced improvements over time, with a median percent reduction in seizures after one year of RNS treatment higher than that observed in focal epilepsy trials leading to FDA approval [6][13] 4. **Clinical Need**: The data provides new hope for the IGE community, which has historically had limited treatment options [6][15] 5. **Study Design**: The NAUGHTLIST study was a prospective, multicenter, randomized, single-blind, sham-controlled trial involving 100 participants, with a focus on patients with drug-resistant IGE [8][9] 6. **Long-term Efficacy**: Data on longer-term seizure outcomes is encouraging, with median percent seizure reductions showing progressive improvement over time [12][14] 7. **FDA Engagement**: NeuroPace plans to submit the full dataset to the FDA in the second half of 2025 and is committed to engaging with the FDA regarding the potential for labeling aligned with the substantial subpopulation showing therapeutic benefit [15][18] 8. **Market Opportunity**: The total market for generalized epilepsy is estimated at around $800 million, with a significant portion likely represented by the subgroup that showed the highest clinical benefit [22][23] 9. **Growth Strategy**: The company’s base business is growing over 20% year over year, and the long-term strategy remains focused on expanding access to personalized therapy for epilepsy patients [19][70] Additional Important Content 1. **Forward-Looking Statements**: The call included forward-looking statements regarding projections, business opportunities, and market conditions, which involve risks and uncertainties [3][4] 2. **Patient Population Insights**: The trial included patients with severe IGE, and the majority had a lower frequency of generalized tonic-clonic seizures, which is reflective of the real-world patient population [25][62] 3. **Ongoing Analysis**: Further analyses are being conducted to understand patient characteristics that differentiate responses to treatment [12][38] 4. **Regulatory Designation**: The FDA granted breakthrough designation for the trial, recognizing it as a novel therapy addressing an unmet clinical need [64] 5. **Long-term Guidance**: The company’s long-term guidance remains unchanged, with ongoing discussions with the FDA and a commitment to advancing treatment options for IGE patients [70][71]

法国巴黎银行财富管理香港首席投资策略师谭慧敏认为，科企早前公布的季绩表现属预期之内。在 Deepseek相关的利好因素消退后，市场需要有新消息憧憬，企业收入或盈利指引胜预期，会是下一个催 化剂。现时选股应避开竞争强劲的范畴，如外卖平台，反而手游企业收入能见度高，配合中央持续发布 游戏版号，可看高一线。(智通财经) ...

数据ETF（516000）及其联接基金（A类：020335；C类：020336；D类：023779）紧密跟踪中证大数据产业指数，成分股 主要聚焦DeepSeek、AI算力、鸿蒙产业链等热门概念板块，覆盖科大讯飞、中科曙光、浪潮信息、恒生电子等热门个 股，为投资者把握算力领域投资机会。 （文章来源：每日经济新闻） 5月26日早盘，A股三大股指在早盘小幅低开，而数据ETF（516000）标的指数中证大数据产业指数全线飘红。截至5月26 日11:13，中证大数据产业指数强势上涨1.35%，成分股中国长城上涨3.69%，石基信息上涨3.13%，润泽科技上涨3.08%， 易华录、中国软件等个股跟涨。数据ETF（516000）上涨1.36%，最新价报0.89元。拉长时间看，截至5月23日，数据ETF 近1年累计上涨30.71%，涨幅排名可比基金第一。 流动性方面，数据ETF盘中换手2.39%，成交997.44万元。从资金净流入方面来看，数据ETF近3天获得连续资金净流入， 最高单日获得445.37万元净流入，合计"吸金"805.74万元，日均净流入达268.58万元。 消息方面，5月25日，市值3164亿元的国产CPU龙 ...

专题：2025基金高质量发展大会 A股市场情绪回升牛股频现，政策暖风频吹下反弹行情启动，开户跟进>> 责任编辑：张恒星 在圆桌对话——《大金融、军工机会何时爆发》中，国泰基金量化投资部金融工程总监、基金经理艾小 军先生分享了军工行业的投资理念，他表示投资军工行业的经历了是非常纠结和非常艰辛的历程，我们 知道以前我们的武器只能看看，因为我们也没有机会给大家露脸，刚才主持人提到，我们露脸的时候相 比以前多了很多，包括每两年的航展等。这些大家看了以后非常的激动，我们也看到国内最先进的武器 和飞机。 大家看的时候，原来的感觉是一个表演，没有机会在战场上看，但在新闻里会看到很多演习。这次印巴 把我们的歼10C，在战场上给我们见识了一下，不仅仅是给我们见识了一下，也给全球见识了中国航 空、中国军工产业。经过这么多年发展，我们用"军工人"的话，原来是望其项背，逐步到同台竞技，这 次印巴的歼10C和PD15E，成体系的把中国军工能力和实力体现出来了。 今年中国军工的DeepSeek时刻非常精准的概括行业的发展，落地到订单上，除了传统的合作伙伴以 外，肯定会有新的拓展，我们都在等待新的进度。 5月24日，由新浪财经主办的202 ...